| Previous Section | Index | Home Page |
Prophylactic Mastectomy Registry
3.33 pm
Ms Joan Ruddock (Lewisham, Deptford): I beg to move,
- That leave be given to bring in a Bill to establish a United Kingdom registry of women who have undergone prophylactic mastectomy surgery.
My interest is both personal and scientific. Like so many people--MPs are no exception--I have breast cancer in my family and I receive regular screening in the NHS. I also have an interest in genetics, having spent the early years of my professional life studying and working on that subject at Imperial college, albeit with micro- organisms, not people.
Breast cancer is the most common form of cancer in women, with one in 12 women developing the disease and more than 34,000 new cases diagnosed in the UK each year.
Awareness of breast cancer is high thanks to the numerous campaigns mounted by women's organisations and the cancer charities. Furthermore, recent statistics show that there has been an improvement in breast cancer survival rates in all European countries, including the United Kingdom, as a result of improvements in treatment. However, the more we women take charge of our own health, and the better informed we become, the more difficult it is for the medical profession to give advice.
There are no absolute predictions to be made about the development of this disease. All that women can expect is to receive advice based on the most comprehensive data that can be gathered. Most women are aware that a family history of breast cancer is likely to be significant, and there is a growing awareness that it is possible to develop the disease because of an inherited genetic abnormality.
Only 5 to 10 per cent. of breast cancers are thought to be the result of genetic mutations, yet worried women with a family history form a disproportionately large number of those referred to specialist breast clinics. Most will not actually have an increased risk because their close relative will not be carrying a mutant gene, but there is no simple or sure way of knowing. Some of the genes responsible have been identified; many others remain to be discovered.
The women who are most likely to be at risk of carrying an abnormal gene often have either a mother or sister diagnosed with breast cancer in their early 30s or 40s, plus several other members of the family similarly affected. If a young woman with breast cancer is found to have a genetic mutation, it is reasonable to test whether close relatives have inherited the risk, of which there is a 50:50 chance.
In those circumstances, half the women tested will be reassured that they do not have the susceptibility of their mother or sister, but the other half will be told that they
have a genetic mutation which predisposes them to a breast cancer risk over a lifetime of 56 per cent. What are those women to do? What are the many women with strong family histories but no genetic screening to do?
Some will feel able to live with the risk, accept close medical surveillance or enter into a trial preventive drug programme such as that carried out with tamoxifen,but, increasingly, women in high-risk categories are undertaking the most radical preventive action of all--they are having both healthy breasts surgically removed.
I have no doubt that, on the basis of the available evidence, those women--we believe that they number between 200 and 500 a year in the United Kingdom--are making an entirely rational decision. As one of them told columnist Jenni Murray in The Express:
The proposal for such a registry comes not originally from me, but from one of the UK's most eminent breast cancer consultants, Professor Ian Fentiman, of Guy's hospital. It is his view that nothing less than a national register will enable us to gain a full picture of the value of those operations.
The only available data come from a retrospective study of 639 women who underwent bilateral prophylactic mastectomy in the United States at the Mayo clinic between 1960 and 1993. Professor Fentiman believes that that study is too small to give dependable statistics that would allow surgeons to compare the efficacy of the different forms of operation involved. Furthermore, and more significantly, that survey was conducted on women who were treated before genetic testing was a reality.
I see no alternative to a UK register of those operations, and a compulsory register at that. Such compulsory notification does not break new ground. We already have a national cancer registry into which details of cancer diagnoses are entered. Pathologists, who are already familiar with such record keeping, would simply be required to record details of the preventive operations in a similar way. Once a registry of all prophylactic mastectomies had been set up and linked to a register of all breast cancer patients, we would have the means of properly assessing preventive mastectomy.
In addition to my sponsors in the House, to whom I am extremely grateful, my proposal has the support of Imperial Cancer Research, the UK Breast Cancer Coalition and the Royal College of Nursing.
Women who are seeking genetic testing and having to make the decision whether or not to undergo mastectomy are frightened and uncertain. We owe it to those women and to their families to use every means at our disposal to make that decision as informed as possible. The very least that surgeons should be able to offer them is advice based on proper statistics and proper research. A national registry of prophylactic mastectomies would be a first and vital step towards achieving that and aiding all of us--our scientists, our surgeons and women ourselves--in defeating this pernicious disease.
Question put and agreed to.
Bill ordered to be brought in by Ms Joan Ruddock, Ms Judith Church, Mr. Frank Doran, Dr. Ian Gibson, Dr. Evan Harris, Miss Julie Kirkbride, Dr. Ashok Kumar, Ms Jackie Lawrence, Mrs. Alice Mahon, Laura Moffatt, Ms Julie Morgan and Ms Dari Taylor.
Ms Joan Ruddock accordingly presented a Bill to establish a United Kingdom registry of women who have undergone prophylactic mastectomy surgery: And the same was read the First time; and ordered to be read a Second time on Friday 26 February, and to be printed [Bill 37].
Madam Speaker:
I have selected the amendment in the name of the Prime Minister. I remind the House that Back-Bench speeches must be limited to 15 minutes.
Mr. Andrew MacKay (Bracknell):
I beg to move,
I shall set the scene by giving some statistics that have been prepared by Families Against Intimidation and Terror, a non-sectarian organisation that is doing marvellous work to help the victims of such mutilations and beatings, giving them hope, succour and, at times, protection and, sadly, at other times, spiriting them out of the country to safety.
"I can live without my breasts but I don't want to die because of them."
The stark truth is that no one can be certain that those drastic measures, which carry with them risk and trauma, will guarantee a lifetime free of breast cancer. It is for that reason that I am introducing a Bill to establish a UK-wide register of all women who undergo preventive mastectomy. The register would record who had the operations, where and for what reason. Over time, such a register would enable consultants to give women a precise statistical account of the effectiveness of those preventive operations.
3.44 pm
That this House condemns the alarming increase in the numbers of terrorist beatings, mutilations, shootings, cases of intimidation and instances of people being forced to leave their homes in Northern Ireland; notes that these are being carried out by organisations whose political representatives backed the Belfast Agreement; further notes that these continued attacks are clear breaches of the Belfast Agreement that required a commitment to exclusively democratic and peaceful methods and that terrorist ceasefires had to be complete and unequivocal; recalls that the Prime Minister said that for terrorist organisations to benefit from prisoner release schemes there must be an end of violence including bombings, killings and beatings; and calls upon Her Majesty's Government to use its powers contained in the Northern Ireland (Sentences) Act 1998 to halt the early release of terrorist prisoners until violence in Northern Ireland has ended in all its forms.
It is the duty of the House to debate the serious issue of the mutilations, torture and beatings, which are increasing in Northern Ireland. I know that I speak for every hon. Member who has taken his or her place in the Chamber in saying that this House unequivocally condemns those horrendous, nauseating and brutal attacks.
| Next Section
| Index | Home Page |